Page last updated: 2024-08-23

selegiline and Neurofibromatosis 1

selegiline has been researched along with Neurofibromatosis 1 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Brown, JA; Diggs-Andrews, KA; Gutmann, DH; Mach, RH; Wozniak, DF; Xu, J	1

Other Studies

1 other study(ies) available for selegiline and Neurofibromatosis 1

Article	Year
PET imaging for attention deficit preclinical drug testing in neurofibromatosis-1 mice. Experimental neurology, 2011, Volume: 232, Issue:2 Topics: Animals; Attention; Attention Deficit Disorder with Hyperactivity; Carbon Radioisotopes; Corpus Striatum; Dopamine Antagonists; Dopamine Uptake Inhibitors; Dopaminergic Neurons; Drug Evaluation, Preclinical; Methylphenidate; Mice; Mice, Inbred C57BL; Mice, Neurologic Mutants; Neurofibromatosis 1; Neuroprotective Agents; Positron-Emission Tomography; Presynaptic Terminals; Raclopride; Selegiline	2011

Article

Year

PET imaging for attention deficit preclinical drug testing in neurofibromatosis-1 mice.

Experimental neurology, 2011, Volume: 232, Issue:2

Topics: Animals; Attention; Attention Deficit Disorder with Hyperactivity; Carbon Radioisotopes; Corpus Striatum; Dopamine Antagonists; Dopamine Uptake Inhibitors; Dopaminergic Neurons; Drug Evaluation, Preclinical; Methylphenidate; Mice; Mice, Inbred C57BL; Mice, Neurologic Mutants; Neurofibromatosis 1; Neuroprotective Agents; Positron-Emission Tomography; Presynaptic Terminals; Raclopride; Selegiline

2011